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The immunological mechanisms responsible for the
anti-allergic effects of probiotic bacteria are still poorly
defined. We tested the effect of a probiotic mixture
(VSL#3) in in vitro, ex vivo and in vivo mouse systems.
In vitro co-culture of naïve bone marrow(BM)-derived
DC (BM-DC) with VSL#3 induced the up-regulation of
maturation marker and IL-10 and IL-12 production. Ex
vivo analysis of mesenteric lymph node(MLN)-derived
DC (MLN-DC) from naïve mice receiving for three
weeks VSL#3 by oral administration, indicated a differ-
ent distribution and phenotype of DC within the MLN.
In particular, VSL#3 treatment increased the frequency
of plasmacytoid DC (pDC, B220+CD11clow), and upre-
gulated the expression of maturation markers on con-
ventional DC (cDC). Moreover, the frequency of IL-10-
expressing cDC was increased. This finding was paral-
leled by the increase of CD4+CD25+ T cells and CD4
+CD25- populations showing enhanced IL-10 produc-
tion. Altogether, these results suggest that VSL#3 treat-
ment can stimulate in the gut the activation of
tolerogenic DC. Finally, we obtained in vivo preliminary
data on therapeutic and preventive potential of VSL#3
in a mouse model of sensitization and anaphylaxis to
peanut. Mice were orally sensitized and challenged with
peanut extract to induce in vivo anaphylaxis. In the
therapeutic experimental setting, animals received a
three-weeks oral treatment with VSL#3 and were then
re-challenged. In the preventive setting, oral probiotic
treatment started one week before the beginning of the
immunization schedule and continued until the
challenge. In both approaches, VSL#3 was able to
reduce anaphylaxis symptoms and IL-13 release in the
jejunum of immunized mice upon post-treatment chal-
lenge. Furthermore, the therapeutic approach also
induced allergen-specific IgA in the gut and TGF-b
release. Then, the capacity of probiotics to induce pro-
tective immune responses linked to counter-regulation
of Th2 responses might become an effective strategy in
the treatment of type I allergy.
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